ELAN
Elanco Animal Health Incorporated
NEW YORK STOCK EXCHANGE, INC.· Pharmaceuticals· US· IPO 2018-09-20
$24.57
+0.47 (+1.95%)
last quote
Want the full multi-source brief on ELAN?
The agent pulls regulatory filings, news flow, prediction-market pricing, and macro context — then synthesizes what's not yet in the price.
Today
Open
$24.57
High
$24.81
Low
$24.09
Previous close
$24.10
Fundamentals
Market cap
$12.27B
P/E (TTM)
—
P/S (TTM)
2.44x
P/B
1.72x
Gross margin
55.36%
Operating margin
-3.33%
Net margin
-3.96%
Rev growth (YoY)
11.95%
EPS growth (YoY)
—
ROE
-3.02%
52W high
$27.98
52W low
$19.40
Beta
1.75x
Industry peers
by market cap
Upcoming earnings
next 30 days
2026-11-06tomorrowbefore market
Q3 2026EPS est $0.21Rev est $1232.1M
Recent SEC filings
CIK 1739104filing-language history →
Recent news
2026-10-28 → 2026-11-04
SeekingAlpha · 10h
Zoetis: Near-Term Expectations More Achievable, Long Growth Runway Undervalued
Zoetis is emerging from a period of underperformance, with market expectations for Q3 and Q4 set notably low. Read why ZTS stock is a speculative Buy.
Yahoo · 22h
Elanco to Participate in UBS Global Healthcare Conference
Elanco Animal Health Incorporated (NYSE: ELAN) will attend the UBS Global Healthcare Conference on November 9, 2026. Bob VanHimbergen, executive vice president and CFO, and Bobby Modi, executive vice president U.S. Pet Health and Global Digital Transformation will participate in a fireside chat on Monday, November 9 at 1:15 p.m. EST.
Yahoo · 1d
IDEXX Soars 20% on Beat-and-Raise Quarter: “Early Innings of a Broad-Based Innovation Cycle”
Key TakeawaysIDEXX Laboratories shares jumped 20% after a third-quarter beat and a raised 2026 outlook. New inVue Dx analyzers are driving recurring test revenue, with in-clinic consumables up 15% organically.
Yahoo · 1d
RadNet (RDNT) Reports Next Week: Wall Street Expects Earnings Growth
RadNet (RDNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Yahoo · 4d
4 Medical Stocks With a Healthy Shot at Q3 Earnings Beats
VTRS, RVTY, ELAN and VCYT have earnings beat signals ahead of Q3 results. Can drug launches, lab spending and cancer tests overcome margin pressures?
Yahoo · 4d
Elanco Animal Health Incorporated (ELAN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Elanco Animal Health (ELAN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Yahoo · 5d
APA Gears Up to Report Q3 Earnings: Here's How It Will Fare
APA Corporation is set to report Q3 2026 results, with higher oil prices potentially boosting revenues, while rising operating expenses could pressure earnings.
Benzinga · 5d
Morgan Stanley Maintains Equal-Weight on Elanco Animal Health, Lowers Price Target to $25
Morgan Stanley analyst Erin Wright maintains Elanco Animal Health (NYSE:ELAN) with a Equal-Weight and lowers the price target from $26 to $25.
This is the free preview
The agent layer adds regulatory-language drift detection, cross-venue prediction-market signals, macro overlays, programmable alert rules, overnight briefs, and a grounding verifier on every claim. 7-day Pro trial, no card required.
Start the trial